Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Temarotene

😃Good
Catalog No. T17034Cas No. 75078-91-0
Alias Ro 15-0778

Temarotene (Ro 15-0778) is an orally active and potent small molecule compound that modulates human immune function in vitro.Temarotene may be used in the study of lichen planus.

Temarotene

Temarotene

😃Good
Purity: 97.54%
Catalog No. T17034Alias Ro 15-0778Cas No. 75078-91-0
Temarotene (Ro 15-0778) is an orally active and potent small molecule compound that modulates human immune function in vitro.Temarotene may be used in the study of lichen planus.
Pack SizePriceAvailabilityQuantity
1 mg665 €6-8 weeks
5 mg1.710 €6-8 weeks
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:97.54%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Temarotene (Ro 15-0778) is an orally active and potent small molecule compound that modulates human immune function in vitro.Temarotene may be used in the study of lichen planus.
Targets&IC50
ODC mRNA:0.5 μM
In vitro
The study examines how retinoids regulate ornithine decarboxylase (ODC) gene expression in human keratinocyte cultures grown in a serum-free environment with 0.15 mM Ca2+. Keratinocytes were treated with varying concentrations (0.1 nM to 10 μM) of all-trans-retinoic acid, 13-cis-retinoic acid, or arotinoid Ro15-0778. Following a 24-hour treatment, a dose-dependent decrease in ODC mRNA levels was observed, with both types of retinoic acids showing an estimated half-maximal inhibitory concentration (IC50) of about 10 nM, and Ro15-0778 being slightly less potent with an IC50 of approximately 0.1-0.5 μM. This suppression of ODC mRNA was noticeable after about 3 hours of treatment, reaching near maximum inhibition by 12 hours. Further analysis revealed that a 24-hour exposure to 0.5 μM all-trans-retinoic acid not only decreased ODC mRNA levels but also reduced ODC enzyme activity significantly.
In vivo
This preliminary study aims to evaluate the plasma and skin concentrations of Ro 15-0778 and its phenolic metabolite Ro 14-6113 in hairless rats administered an oral dose of 10 mg/kg Temarotene daily for 10 days. By collecting blood (2-3 mL) and skin (200-300 mg) samples at intervals from 0.5 to 240 hours post the final dose, the study utilizes a sensitive HPLC method for the concurrent analysis of both compounds, achieving detection limits of 2 ng/mL in plasma and 10 ng/g in total skin (epidermis and dermis). Results indicate that, after 10 hours, plasma levels of Ro 14-6113 were found to be 5-13 times greater than those of Ro 15-0778, and 4-10 times higher in skin within the initial 48 hours. Notably, the skin concentrations of both compounds exceeded their respective plasma levels.
AliasRo 15-0778
Chemical Properties
Molecular Weight304.47
FormulaC23H28
Cas No.75078-91-0
SmilesCC1(C)C=2C(C(C)(C)CC1)=CC=C(\C(=C\C3=CC=CC=C3)\C)C2
Relative Density.0.963g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Temarotene | purchase Temarotene | Temarotene cost | order Temarotene | Temarotene chemical structure | Temarotene in vivo | Temarotene in vitro | Temarotene formula | Temarotene molecular weight